1. Home
  2. PTLE vs ATRA Comparison

PTLE vs ATRA Comparison

Compare PTLE & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PTLE

PTL LTD Ordinary Shares

HOLD

Current Price

$6.01

Market Cap

42.2M

Sector

Energy

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$4.76

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTLE
ATRA
Founded
2013
2012
Country
Singapore
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.2M
38.9M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PTLE
ATRA
Price
$6.01
$4.76
Analyst Decision
Sell
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
16.3K
58.9K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
122.52
EPS
N/A
2.57
Revenue
N/A
$120,772,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.91
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$3.92
52 Week High
$16.17
$19.15

Technical Indicators

Market Signals
Indicator
PTLE
ATRA
Relative Strength Index (RSI) 44.99 44.92
Support Level $0.13 $4.70
Resistance Level $9.00 $5.47
Average True Range (ATR) 0.58 0.31
MACD -0.18 -0.00
Stochastic Oscillator 10.15 22.39

Price Performance

Historical Comparison
PTLE
ATRA

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Share on Social Networks: